Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Development, preliminary usability and accuracy testing of the EBMT ‘eGVHD App’ to support GvHD assessment according to NIH criteria—a proof of concept
Ist Teil von
Bone marrow transplantation (Basingstoke), 2016-08, Vol.51 (8), p.1062-1065
Ort / Verlag
London: Nature Publishing Group UK
Erscheinungsjahr
2016
Quelle
MEDLINE
Beschreibungen/Notizen
The EBMT Complications and Quality of Life Working Party has developed a computer-based algorithm, the ‘
e
GVHD
App
’, using a user-centered design process. Accuracy was tested using a quasi-experimental crossover design with four expert-reviewed case vignettes in a convenience sample of 28 clinical professionals.
Perceived usefulness
was evaluated by the technology acceptance model (TAM) and
User satisfaction
by the Post-Study System Usability Questionnaire (PSSUQ). User experience was positive, with a median of 6 TAM points (interquartile range: 1) and beneficial median total, and subscale PSSUQ scores. The initial standard practice assessment of the vignettes yielded 65% correct results for diagnosis and 45% for scoring. The ‘
e
GVHD
App
’ significantly increased diagnostic and scoring accuracy to 93% (+28%) and 88% (+43%), respectively (both
P
<0.05). The same trend was observed in the repeated analysis of case 2: accuracy improved by using the App (+31% for diagnosis and +39% for scoring), whereas performance tended to decrease once the App was taken away. The ‘eGVHD
App
’ could dramatically improve the quality of care and research as it increased the performance of the whole user group by about 30% at the first assessment and showed a trend for improvement of individual performance on repeated case evaluation.